Article History
Received: 27 October 2020
Revised: 17 December 2020
Accepted: 1 February 2021
First Online: 8 March 2021
Declarations
:
: The scientific guarantor of this publication is Madan Rehani.
: Madan Rehani and Vinit Baliyan declare no conflict of interest. John Heil is Co-Founder and CEO of Imalogix, but there is no intent in the paper to compare the product of Imalogix with any other company and thus, there is no conflict of interest.
: None
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained as indicated in the “” section.
: • Retrospective• Observational• multicenter study